Yarrow Bioscience (YARW) Times Interest Earned (2017 - 2025)
Yarrow Bioscience's (YARW) quarterly Times Interest Earned came in at -$3771.0 in Q2 2025, down 2003.87% YoY from $198.07 in Q2 2024, and down 3620.8% on a QoQ basis from -$101.35 in Q4 2024.
Yarrow Bioscience (YARW) Times Interest Earned (2017 - 2025) Analysis & Trends
Yarrow Bioscience (YARW) has 9 years of Times Interest Earned data on file, last reported at -$3771.0 in Q2 2025.
- Quarterly Times Interest Earned fell 2003.87% year-over-year to -$3771.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$21300.0 (down 3905.58% YoY) and the FY2025 annual result came in at -$265.62, down 61195.55% from the prior year.
- Times Interest Earned declined to -$3771.0 in Q2 2025, from -$101.35 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $2.74 in Q4 2021 to a low of -$6545.5 in Q3 2024.
- A 5-year average of -$784.33 and a median of -$57.12 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned soared 118.14% — and 2024, when it plunged 31399.04%.
- Tracing YARW's Times Interest Earned over 5 years: stood at $2.74 in 2021, then plunged by 3010.74% to -$79.84 in 2022, then tumbled by 31.65% to -$105.11 in 2023, then advanced by 3.58% to -$101.35 in 2024, then sank by 3620.8% to -$3771.0 in 2025.
- The last three Times Interest Earned figures came in at -$3771.0 (Q2 2025), -$101.35 (Q4 2024), and -$6545.5 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -3,771.00 |
| Dec 31, 2024 | -101.35 |
| Sep 30, 2024 | -6,545.50 |
| Jun 30, 2024 | -179.24 |
| Mar 31, 2024 | -105.43 |
| Dec 31, 2023 | 139.43 |
| Sep 30, 2023 | -20.78 |
| Jun 30, 2023 | -34.39 |
| Mar 31, 2023 | -19.58 |
| Dec 31, 2021 | -2.74 |
| Sep 30, 2021 | -3.10 |
| Jun 30, 2021 | -8.88 |
| Mar 31, 2021 | -9.19 |
| Dec 31, 2020 | 11.70 |
| Sep 30, 2020 | -21.51 |
| Jun 30, 2020 | -156.24 |
| Mar 31, 2020 | -37.38 |
| Dec 31, 2019 | -115.17 |
| Sep 30, 2019 | -8.24 |
| Jun 30, 2019 | -3.38 |